NOVONIX Ltd Files 6-K with Director Holdings Update
Ticker: NVNXF · Form: 6-K · Filed: Sep 24, 2024 · CIK: 1859795
Sentiment: neutral
Topics: insider-filing, director-holdings, sec-filing
TL;DR
NOVONIX filed a 6-K showing director/officer stock changes. Standard disclosure.
AI Summary
NOVONIX Limited filed a Form 6-K on September 24, 2024, reporting changes in director/principal officer holdings. Specifically, the filing includes an Appendix 3Y, which details changes in the relevant interests of directors and principal officers. This is a routine disclosure for listed companies.
Why It Matters
This filing provides transparency into the stock ownership of NOVONIX's key personnel, which can offer insights into their confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of director and officer stock transactions, which typically carries low risk.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- Appendix 3Y (document) — Included exhibit detailing changes in director/principal officer holdings
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the primary purpose of this 6-K filing?
The primary purpose is to report changes in the relevant interests of directors and principal officers, as indicated by the inclusion of Appendix 3Y.
When was this filing submitted?
The filing was submitted on September 24, 2024.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Does NOVONIX Limited file annual reports under Form 20-F or 40-F?
Yes, NOVONIX Limited indicates it files annual reports under cover of Form 20-F.
Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2024-09-24 17:17:20
Filing Documents
- nvx-6k-sep-24-09-23-app3.htm (6-K) — 19KB
- nvx-ex99_1.htm (EX-99.1) — 53KB
- nvx-ex99_2.htm (EX-99.2) — 78KB
- img59892534_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-109127.txt ( ) — 153KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: September 24, 2024